Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy

Cited by (124)

Items 101–124 of 124

1. Genomic Alterations of KRAS and NRAS in B&H Colorectal and Non-small Cell Lung Cancer Patients
   Lejla-Nur Smajović, Dino Pećar, Lana Salihefendić, Altijana Hromić‐Jahjefendić, Rijad Konjhodžić · 2021 · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany
2. Transcriptomics in Tumor and Normal Tissues and Precision Oncology Algorithms Identify Early-Stage NSCLC Patients with High Risk of Post-Surgery Recurrence Who May Benefit from Adjuvant Therapies
   Vladimir Lazar, Éric Raymond, Nicolas Girard, Jean‐François Martini, Susan M. Galbraith, Jacques Raynaud, Catherine Bresson, Benjamin Maurice Solomon, Shai Magidi, Hovav Nechushtan et al. · 2021 · SSRN Electronic Journal
3. Data from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
   Noura J. Choudhury, Jessica A. Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran, Hira A. Rizvi, Kathryn Cecilia Arbour, Karissa A. Whiting, Ronglai Shen et al. · 2023
4. Data from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
   Noura J. Choudhury, Jessica A. Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran, Hira A. Rizvi, Kathryn Cecilia Arbour, Karissa A. Whiting, Ronglai Shen et al. · 2023
5. Data from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
   Noura J. Choudhury, Jessica A. Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran, Hira A. Rizvi, Kathryn Cecilia Arbour, Karissa A. Whiting, Ronglai Shen et al. · 2023
6. Presentation and Outcomes of KRAS G12C Mutant Non-Small Cell Lung Cancer Patients with Stage IV Disease at Diagnosis (de novo) Versus at Recurrence
   Niki Esfahanian, Sze Wah Samuel Chan, Luna Jia Zhan, Mary Catherine Brown, Khaleeq Khan, Jae Lee, Karmugi Balaratnam, Elizabeth Yan, Jennifer Parker, Miguel García-Pardo et al. · 2023 · SSRN Electronic Journal
7. A case report and literature review of a rare primary multiple small intestinal sarcomatoid carcinoma with co-driver gene mutations
   Dan Liu, Xulin Li, Hui Xie, Yi Wen Tang, Yanhong Xie, Qing Cheng Li, Birong Yin, Wu Luo, Xiaohua Ruan · 2024 · Research Square
8. Establish a novel immune-related gene prognostic risk index (IRGPRI) associated with CD8+ cytotoxic T lymphocytes in non-small-cell lung cancer (NSCLC)
   Shenjing Cui, Yikun Yang, Shuang Lou, Rong Huang, Jing Wang, Zhongbiao Chen, Jingjing Xie · 2024 · Heliyon
9. Bioinformatics-based analysis of nicotinamide adenine dinucleotide metabolism-related genes to predict immune status and prognosis for head and neck squamous cell carcinoma patients
   Zhenjie Guan, Xinyu Gu, Lian Zheng · 2025 · Frontiers in Immunology
10. Additional file 9 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
    Qin, Kang, Hou Helei, Liang, Yu, Zhang, Xiaochun · 2020 · Figshare
11. Additional file 4 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
    Qin, Kang, Hou Helei, Liang, Yu, Zhang, Xiaochun · 2020 · Figshare
12. Additional file 7 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
    Qin, Kang, Hou Helei, Liang, Yu, Zhang, Xiaochun · 2020 · Figshare
13. Additional file 1 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
    Qin, Kang, Hou Helei, Liang, Yu, Zhang, Xiaochun · 2020 · Figshare
14. Additional file 6 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
    Qin, Kang, Hou Helei, Liang, Yu, Zhang, Xiaochun · 2020 · Figshare
15. Additional file 2 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
    Qin, Kang, Hou Helei, Liang, Yu, Zhang, Xiaochun · 2020 · Figshare
16. Additional file 11 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
    Qin, Kang, Hou Helei, Liang, Yu, Zhang, Xiaochun · 2020 · Figshare
17. Additional file 3 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
    Qin, Kang, Hou Helei, Liang, Yu, Zhang, Xiaochun · 2020 · Figshare
18. Additional file 5 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
    Qin, Kang, Hou, Helei, Liang, Yu, Zhang, Xiaochun · 2020 · Figshare
19. Additional file 10 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
    Qin, Kang, Hou, Helei, Liang, Yu, Zhang, Xiaochun · 2020 · Figshare
20. Additional file 1 of Molecular fingerprints of nuclear genome and mitochondrial genome for early diagnosis of lung adenocarcinoma
    Xu, Yichun, Yong Yang, Wang, Yichao, Su, Jun, Tianlong Chan, Zhou, Jiajing, Gong, Yi, Ke Wang, Gu, Yifeng, Congmeng Zhang et al. · 2023 · Figshare
21. Additional file 8 of Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis
    Qin, Kang, Hou, Helei, Liang, Yu, Zhang, Xiaochun · 2020 · Figshare
22. Molecular bycatch in early-stage NSCLC: Keep, discard, or redefine?
    N. Frost, Ludovica Mollica, Roberto Ferrara · 2026 · European Journal of Cancer
23. Optimisation de la planification dosimétrique chez les patients atteints de cancer du poumon traités par radiothérapie : développement de nouveaux outils de prédiction par des approches d'apprentissage automatique
    Vincent Bourbonne · 2022
24. Association of tumor mutational burden and tumor-infiltrating lymphocytes with second primary cancer after complete resection of non-small cell lung cancer
    Marie-Pier Gauthier, Maryam Karimi, Stefan Michiels, Lesley Seymour, Elisabeth M. Brambilla, Thierry Le Chevalier, Jean‐Charles Soria, Robert Arthur Kratzke, Stephen L. Graziano, Ramaswamy Govindan et al. · 2026 · Frontiers in Oncology